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Abstract
Background: The present study investigated the effect of peforelin (Maprelin®), a gonadotropin-releasing hormone
(GnRH) analogue, administration in gilts, primiparous and pluriparous sows in a high productive farm on sow
reproductive performance and piglet quality at birth.
Methods: In a 400 sow herd, gilts, primiparous and pluriparous sows were randomly allocated to 2 groups:
peforelin treated (peforelin = P-group) or no treatment (control = C-group). Animals were injected 48 h after the last
altrenogest treatment (gilts) or 24 h post weaning (sows). Weaning-to-estrus interval (WEI), estrus rate (ER),
farrowing efficiency index (FEI), farrowing rate (FR), number of total (TBP), live (LBP) and stillborn piglets (SBP),
mummies (MM) and live piglet index (LPI) were assessed and compared between treatment groups. To assess
piglet quality at birth, 6033 piglets from 426 litters were weighed individually within 24 h after birth (BW; birth
weight).
Results: No significant difference between treatment groups could be observed for WEI, TBP, LBP, SBP and MM.
The ER was significantly (P = 0.0119) higher (93.2 %) in the P-group as compared to the C-group (87.2 %). Peforelin
treatment did not affect farrowing rate. Both FEI and LPI were significantly (P = 0.0078) better in the P-group as
compared to the C-group. Overall, no effect of peforelin treatment on piglet birth weight could be observed,
although specific subcategories (1st parity and older (5+ parity) sows) did have a significant impact of treatment on
birth weight. During late summer (August-September) all treated gilts and sows took advantage from peforelin
treatment with a significant improvement of piglet birth weight.
Conclusion: Peforelin treatment had a significant impact on ER, FEI and LPI. Moreover, piglet birth weight
improved for specific sow subcategories (1st parity and older sows) and for all gilts and sows during the late
summer infertility period.
Keywords: Peforelin, GnRH analogue, Farrowing efficiency index, Live piglet index, Reproduction, Piglet birth
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Background
Optimal reproductive performance is crucial for eco-
nomic success in commercial pig herds [28, 32]. Differ-
ent management strategies [24], such as optimized
feeding strategies, hyperprolific dam lines [3], batch far-
rowing systems and extended photoperiod during the
post-weaning phase [6], are applied in order to meet the
high performance expectations of modern sow farmers
[18, 34]. However, inevitable variations in farm condi-
tions, such as season [24, 25], infection pressure or feed
ingredients [10, 18] can negatively impact the results of
high productive genetics. Moreover, recent evidence has
shown that reproductive performance is influenced by
wean-to-estrus (WEI) interval [26].
Pharmaceuticals, such as progesterone-analogues and go-
nadotropins, are used in practice to control reproduction
with the aim to increase the reproductive performance of
gilts and sows [8]. The use of gonadotropins post-weaning
in sows or following altrenogest treatment in gilts, both in
order to stimulate the follicular development, can achieve
an even better synchronization effect [5, 20]. In the mature
pig, natural gonadotropin secretion is controlled through
the release of hypothalamic peptides, gonadotrophin-
releasing hormones (GnRH), which pass through the hypo-
physeal portal vessels to the pituitary gonadotrophs, causing
the release of follicle-stimulating hormone (FSH) and
luteinizing hormone (LH) [22]. GnRH regulates both
FSH, thus playing a key role in growth and matur-
ation, and LH to a certain extent, with final ovulation
of the follicles [5, 21].
The positive influence of peforelin, a I-GnRH-III which
induces an FSH-increase and no LH-increase [38, 39], on
the estrus induction in sows has been shown in Germany
[13, 14]. Using peforelin, the interval between the last altre-
nogest treatment and estrus could be reduced [11, 12] and
an effect on the depression of fertility performance during
the warmer season was shown [13]. Recently, the use of
peforelin in high performing farms has been shown to
shorten the weaning-to-estrus interval in sows [1]. Other
parameters which can be influenced by the use of peforelin
is the farrowing efficiency index (FEI = litters per 100 treat-
ments; [16]) and subsequent litter performance [16, 17].
Following peforelin treatment, an FEI of 82 % was obtained
as compared to 79 % in the placebo group [16].
The purpose of the present study was to investigate
the effect of peforelin treatment in gilts after altrenogest
treatment and in sows post weaning on piglet quality
(birth weight) at birth and sows reproductive perform-
ance in a high productive well-managed sow herd.
Results and discussion
Litter and reproductive performance
All results concerning litter performance (WEI, LBP,
SBP and MM) and reproductive parameters (ER, FR, FEI
and LPI) are shown in Table 1. Taking into account only
the gilts and sows in estrus until 7 d pw (n = 484), no
significant difference in WEI could be detected between
both treatment groups. In the present study, only gilts
and sows in estrus until 7 d pw were taken into account,
since it has been shown that sows coming into estrus
later than 7 d pw are subfertile and from 9 d pw on-
wards, a different surge of ovarian follicles is involved,
which implies that comparison of post-weaning estrus
results becomes impossible [30]. All parameters con-
cerning number of piglets born were not significantly
different. The ER showed significant (P < 0.05) im-
provement following peforelin treatment (P-group) as
compared to the control. Treatment with peforelin did
not impact (P < 0.05) the FR. The FEI was significantly
(P < 0.05) better in the P-group (79.2 %) as compared
to the C-group (70.2 %), resulting in a significant effect
on the LPI (C-group, LPI = 1032; P-group, LPI = 1151;
P < 0.01).
Table 1 Reproductive parameters (WEI; LBP, live born piglets; SBP,
stillborn piglets; MM, mummies) and reproduction indicators (ER,
estrus rate; FR, farrowing rate; FEI, farrowing efficiency index; LPI, live
piglet index) for both treatment groups (C-group, control
group, n = 289; P-group, peforelin-treated group, n = 279) and
different parity groups (gilts, 1st parity sows, 2nd–4th parity
sows and 5+ parity sows), expressed as means ± SEM and
their significance level
C-group P-group Significance level
WEI overall 6.11 ± 0.33 6.82 ± 0.44 P > 0.05
WEI≤ 7 d pw 5.08 ± 0.26 5.10 ± 0.34 P > 0.05
LBP 14.7 ± 0.20 14.4 ± 0.19 P > 0.05
LBP – gilts 13.76 ± 0.49 13.95 ± 0.47 P > 0.05
LBP – 1st parity 14.47 ± 0.61 13.39 ± 0.53 P > 0.05
LBP – 2nd–4th parity 15.07 ± 0.22 14.73 ± 0.23 P > 0.05
LBP – 5+ parity 13.40 ± 0.079 13.83 ± 0.54 P > 0.05
SBP 0.18 ± 0.07 0.80 ± 0.08 P > 0.05
MM 0.38 ± 0.07 0.28 ± 0.04 P > 0.05
ER 87.2 % 93.2 % P < 0.05
FR 81.3 % 85.7 % P > 0.05
FEI 70.9 % 79.9 % P < 0.05
FEI – gilts 42.9 % 82.6 % P < 0.0001
FEI – 1st parity 65.5 % 74.2 % P > 0.05
FEI – 2nd–4th parity 78.5 % 82.5 % P > 0.05
FEI – 5+ parity 71.4 % 68.5 % P > 0.05
LPI 1032 1151 P < 0.01
LPI – gilts 590 1152 P < 0.0001
LPI – 1st parity 948 994 P > 0.05
LPI – 2nd–4th parity 1183 1215 P > 0.05
LPI – 5+ parity 957 947 P > 0.05
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The present study investigated whether peforelin, a
synthetic I-GnRH-III, could influence litter performance,
reproductive parameters and piglet birth weight in gilts
and sows in a high productive sow herd during different
seasonal reproductive conditions.
Although numerical difference could be observed in
litter performance (WEI, LBP, SBP and MM), the treat-
ment with peforelin did not show a significant impact
on any of these parameters. Between both treatment
groups, the WEI showed no significant decrease in the
treatment group as compared to the control group.
These results are in accordance with Engl et al. [14]. In
these studies no differences were observed in WEI be-
tween treatment groups, except for the primiparous
sows treated with PMSG, a product which was not in-
cluded in the present study.
The FEI, takes into account the effect of the treatment
on ER and the number of inseminated sows that farrow
as a result of the insemination following treatment. In
this way, it differs from the traditional FR. Furthermore,
the traditional FR is based on the total number of sows
inseminated and thus also taking into account the litters
of sows returned into estrus. Since the present study
compares peforelin treatment, a product to induce es-
trus, with an untreated control, the innovative perform-
ance parameter FEI is more appropriate to benchmark
the reproductive results between both treatment groups.
The 8.95 % higher FEI in the treated group compared to
the control group (Table 1) can be mainly attributed to
a significant difference in FEI in the gilt subcategory, al-
though the 1st and 2nd-3rd parity sows also showed a
non-significant, numerical tendency for improvement.
No significant difference in FEI throughout the different
study periods could be observed, although numerical
trends showed an improvement in all study periods.
This indicates that GnRH-agonists have little influence
on the outcome of pregnancy [19, 23] and mainly im-
prove estrus performance. An increase of almost 9 % in
FEI may have a significant biological impact on sow farm
management, especially under conditions of batch man-
agement systems, where return-to-estrus and non-
pregnancy can have a major impact on the batch stability.
Looking at FEI in further detail, the impact of peforelin
treatment doubled (P < 0.05) FEI (45 % in C-group to
79 % in P-group) in gilts treated after altrenogest
synchronization.
The results obtained in the present study were from a
farm with good reproductive results (32.4 piglets/sow/
year), although the reproductive results of the gilts in
the control group could clearly be identified as problem-
atic. However, a previous study [9] performed in farms
with more average reproductive results (approx. 26 pig-
lets/sow/year) also showed significant effects on estrus
rate. Therefore, it can be concluded that peforelin
treatment can be implemented on swine farms with vari-
ous levels of reproductive performance.
Total born piglets (sum of LBP and SBP) did not differ
between control and treatment group, indicating the
safety of the product. Although the number of LBP was
slightly lower in the treated group, the LPI was higher
overall due to the better FEI in the treated animals.
Birth weight
All results concerning birth weight and the effect of treat-
ment, parity and season are shown in Figs. 1, 2 and 3.
Overall, treatment with peforelin did not result in a sig-
nificant increase in BW (Fig. 1). The coefficient of vari-
ation (CV) was identical (24.9 %) in both treatment
groups, indicating no overall difference in homogeneity of
the litters from the C-group compared to the P-group.
When stratification into parities was applied, a significant
impact of peforelin treatment could be observed for 1st
parity sows (P < 0.05) and older sows (5th and older par-
ities) (P < 0.05). For all other parities (gilts and 2nd–4th
parity), no significant effect of peforelin treatment could
be shown throughout the study. This could possibly be ex-
plained by the difference in the number of TBP among
the different groups. Although these differences were non-
significant, 1st parity sow and 5th and older parities had
approximately 0.5 to 1 piglets less born per litter as com-
pared to 2nd-4th parity sows, which is could partly explain
the difference of around 100 g of BW in both these age
groups [3]. Another explanation could be that a uniform
ovulatory follicle pool at the ovary would result in a uni-
form oocyte quality, and an improved the luteal develop-
ment [40] resulting in a better embryo quality [27, 37].
These elements could finally result in more uniform birth
weights [35]. Jourquin and Goossens [17] have also shown
a positive impact of peforelin treatment on the perform-
ance of the subsequent litter, which can be explained by
increase of FSH, needed for follicle development [15],
through peforelin treatment, resulting in larger follicles
Fig. 1 Birth weight (average ± SEM) per treatment group (C-group,
control group, n = 2985; P-group, peforelin-treated group, n = 3048).
Significant differences (P < 0.05) between both treatment groups are
indicated by an asterix (*)
Vangroenweghe et al. Porcine Health Management  (2016) 2:1 Page 3 of 7
and a better pre-ovulatory follicle pool with more compe-
tent follicles to ovulate [11]. First parity sows have a higher
chance of suffering from bad reproductive performance in
their next cycle [29], and therefore the effect of peforelin
treatment on this animal category could have a greater
impact on subsequent litter quality and reproductive pa-
rameters. Older sows on the otherhand, may suffer from
lower reproductive performance, since this is the major
cause of culling at higher parities [7, 9]. From a practical
point of view, peforelin treatment of specific subcategories
of sows within a high productive sow farms could be
advised throughout the year for optimization of repro-
ductive performance.
The effect of seasonality was significant (P < 0.05) with
higher BW in gilts and sows treated with peforelin and in-
seminated during late summer (P2, August–September). In
other periods (P1, June–July and P3, October–November–
December), no effect of peforelin treatment on BW could
be shown.
Late summer infertility and related low reproductive
performance has been described [24, 25]. The effect was
observed in the period of maximal summer infertility
due to photoperiod effects, namely from week 28 till
week 42 [2]. The seasonal change in circadian melatonin
release alters hypothalamic GnRH release, subsequently
affecting LH pulse amplitude and/or frequency [31].
After the first embryonic oestrogenic signal, if the supply
of LH is inadequate, CL production of progesterone may
be insufficient to support appropriate embryonic devel-
opment [4]. Therefore, treatment with peforelin, a
GnRH analogue, could solve this temporary alternation
in endogenous hypothalamic GnRH release. Moreover, a
recent study [9] showed a positive effect of peforelin
treatment on follicle growth in gilts and sows. As previ-
ous explained, this could result in a uniform oocyte
quality, and an improved the luteal development [40]
resulting in a better embryo quality [27, 37] during the
period of summer infertility.
Conclusions
Peforelin treatment had a significant impact on ER, FEI
and LPI. Moreover, piglet birth weight improved for spe-
cific sow subcategories (1st parity and parity 5 or older
sows) and for all sows during the late summer infertility
period. These subcategories are the sows with the high-
est risk of lower piglet quality, as well as the sows insem-
inated during the period of late summer infertility.
Methods
Herd description, study animals and management
practices
A high productive sow herd with 400 Topigs 20 sows
was selected. The number of weaned piglets/sow/year
was above 32 in the last 12 months before the enroll-
ment of the study and per batch, 80 to 92 % of the sows
showed estrus within 7 days after weaning. A detailed
description of the sow herd characteristics is given in
Table 2.
In total, 568 animals (gilts, n = 96; 1st parity sows, n = 60;
multiparous sows, n = 412) were enrolled during at least
one reproductive cycle. Animals with clinical symptoms
and/or reproductive disorders, such as vaginal discharge or
abortions, were excluded from the study. Gilts had been
synchronized with altrenogest (Regumate®; MSD Animal
Health, Brussels, Belgium) for 18 days (20 mg per gilt/day)
after they had shown at least one estrus. To ensure correct
dosing, gilts were housed in individual stalls during altreno-
gest treatment. After altrenogest treatment (gilts) or wean-
ing (sows), animals were moved to a specifically designated
insemination area with individual housing and a light
schedule of at least 16 h per day (150–275 Lux). Repeat
Fig. 2 Birth weight (average ± SEM) per treatment group (C-group,
control group = yellow; P-group, peforelin-treated group = blue) blocked
by season (S1, June–July, LBP = 14.50 ± 0.26; S2, August–September,
LBP = 13.94 ± 0.25; S3, October–November–December, LBP = 14.87 ±
0.20). Significant differences (P< 0.05) between both treatment groups
are indicated by an asterix (*)
Fig. 3 Birth weight (average ± SEM) per treatment group (C-group,
control group = yellow; P-group, peforelin-treated group = blue) blocked
by parity (P0, gilts, LBP = 13.88 ± 0.35; P1, 1st parity, LBP = 13.88 ± 0.40;
P2–4, 2nd to 4th parity, LBP–P2 = 14.79 ± 0.39, LBP–P3 = 14.80 ± 0.24,
LBP–P4 = 15.12 ± 0.26; P5+, 5th and older parities, LBP = 13.61 ± 0.48).
Significant differences (P< 0.05) between both treatment groups are
indicated by an asterix (*)
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breeders were not included as there is no timepoint avail-
able to determine the correct dosing moment.
Estrus stimulation started at 48 h post weaning (pw)
or 72 h after the last altenogest treatment in gilts, using
a teaser boar. All animals were fed ad libitum during the
pre-estrus period. Following insemination and through-
out gestation, a strict feeding schedule was applied with
a lower feeding level after insemination, increasing after
40 d in gestation.
Experimental design
The main objectives of the study were to determine the
effect of the peforelin treatment on piglet quality, de-
fined as piglet birth weight within 24 h after birth and
the effect on reproductive performance of the sows. A
minimum of 250 sows was required per treatment group
(C-group vs. P-group) to be able to detect a difference of
50 g in piglet birth weight between the treatments with
95 % confidence, 80 % power and a standard deviation
of 300 g (WinEpiscope 2.0; [33]). Animals were stratified
according to parity (gilts, 1st parity sows, 2nd to 4th parity
sows and 5th and older parity sows) and randomly allo-
cated to one of both treatment groups at the moment of
injection: peforelin (Maprelin®) or P-group (150 μg
peforelin in gilts and pluriparous sows, 37.5 μg in
primiparous sows, 2 ml resp. 0.5 ml peforelin according
to the manufacturers’ instructions) and negative control
or C-group (no injection). Animals were injected intra-
muscularly on the right-hand side of the neck 24 (±2) h
pw (sows) and 48 (±2) h after the last altrenogest treat-
ment (gilts) (Table 3). The treatments were performed
by the farm veterinarian following randomization by the
investigator. All personnel involved in estrus detection,
insemination, birth weight measurement and collection
of reproductive data were blinded for the group alloca-
tion of the animals. The treatments were performed
from June 2012 to January 2013.
Study period description
To study the effects of peforelin on sows during the
period with highest probability of fertility problems, the
treatment period was clustered into 3 specific study pe-
riods, based on the current knowledge of seasonal repro-
ductive problems [24, 25]. Period 1 was defined as early
summer with treatment performed during June–July
(P1, period 1), period 2 was defined as late summer and
associated with fertility problems mainly during August–
September (P2, period 2) and period 3 was defined as
autumn with treatment performed during October–
November–December (P3, period 3).
Estrus detection and insemination protocol
Estrus detection was performed in sows from 48 h pw
and in gilts from 72 h after the last altrenogest treatment
onwards twice daily, in the morning at 9 am and in the
afternoon at 16 pm, using active boar contact. Sows in
estrus showing a standing reflex in the morning were in-
seminated in the afternoon at 17 pm, whereas sows in
estrus in the afternoon were first inseminated the next
morning at 10 am. If sows were still showing estrus the




The estrus rate (ER) is defined as the proportion of
animals that were in estrus per 100 animals included. All
animals in estrus were inseminated. The farrowing rate
(FR) is defined as the proportion of animals that far-
rowed per 100 inseminations. The farrowing efficiency
Table 2 Characteristics of the high productive sow herd
Herd characteristic
Number of sows 400
Breed Topigs 20
Batch management system (weeks) 4
Lactation length (weeks) 3
Piglets weaned per sow per year 32.4
Average WEI (days ± SEM) 6.5 ± 0.3
Age of gilts at first insemination (days ± SEM) 270 ± 15
Type of housing for pregnant sows
(<4w of gestation)
Individual Stalls
Type of housing for pregnant sows
(>4w of gestation)
Pens with groups of 18
sows
Vaccinations of gilts (weeks post arrival in
quarantine)
● Parvovirus & Erysipelothrix rhusiopathiae 0 – 3
● Escherichia coli 1 – 4
● Atrophic rhinitis 1 – 4
● Porcine Reproductive and Respiratory
Syndrome virus
0 – 3
Vaccinations in sows (weeks pre/postpartum)
● Parvovirus & Erysipelothrix rhusiopathiae +2
● Escherichia coli - 3
● Atrophic rhinitis - 3
● Porcine Reproductive and Respiratory
Syndrome virus
- 7
Table 3 Treatment schedule for peforelin administration in
different sow groups
Sow category Peforelin dose
(75 μg/ml)
Administration timepoint
Gilts 2.0 ml 48 h after last altrenogest
administration
1st parity sows 0.5 ml 24 h post weaning
≥2nd parity sows 2.0 ml 24 h post weaning
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index (FEI) is defined as the proportion of animals that
farrowed per 100 animals included and is therefore an
innovative parameter taking into account both ER and
FR in only one figure. It is calculated as the number of
farrowings divided by the number of gilts and sows en-
rolled post-weaning or post-synchronization. Only ani-
mals inseminated within 7 d pw (n = 484) are taken into
account, since animals coming into estrus later than 7 d
pw (n = 26) are considered as subfertile [30].
Litter parameters
From each litter, the number of live born piglets (LBP),
stillborn piglets (SBP) and mummified piglets (MM) was
recorded. Due to the study blinding, cross fostering could
not be limited within a specific treatment group. There-
fore, the number of weaned piglets could not be correctly
allocated to treatment groups. Based on LBP and FEI, the
live piglet index (LPI) was calculated. The LPI gives the
number of piglets born per 100 animals included. It is cal-
culated as sum of LBP per 100 animals that started their
reproductive cycle pw or post-synchronization. This index
takes into account one step more than the previously de-
fined piglets produced per mated female (PPMF) [36].
Birth weight
Live born piglets were individually weighed (birth weight,
BW; expressed in g) within 24 h after birth and before
cross fostering.
Statistical analysis
Normal distribution of the data was tested using Normal
Quantile Plot. Values in the groups were usually
expressed as means and standard error of the mean
(SEM). To detect differences between groups for LPB,
SBP, MM, ER, WEI, FR, FEI, LPI and BW cross tabula-
tion and the Chi square test were used. Multiple com-
parison for the parameter BW was performed using
ANOVA and pair wise comparisons between groups
were made with the post hoc Bonferroni test. Signifi-
cance was obtained when P < 0.05. The statistical calcu-
lations were performed using the software program JMP
9.0.3. (SAS Institute Inc., Cary, North Carolina, USA).
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